Whenever used in this Chapter the term "synthetic drug" shall mean any product, whether
described as tobacco, potpourri, herbs, incense, spice, aromatic, or any combination
thereof, and whether marketed for the purpose of being smoked, ingested or injected,
or otherwise marketed, which includes, but is not limited to one or more of the following
hallucinogenic substances: 1) 1-Pentyl-3-(1-Naphthoyl) Indole; some trade or other
names: JWH-018; or (2) 1-Butyl-3-(1 naphthoyl) Indole; some trade or other names:
JWH-073; or (3) 1-[2-(4Morpholinyl) Ethyl]-3-(1Naphthoyl) Indole; some trade or other
names; JWH-200; or (4) 5-(1, l-Dimethyloctyl)-2-[(1R, 3S)-3-Hydroxycyclohexyl]-Phenol;
some trade or other names; CP-47, 497; or (5) 5-(1, 1-Dimethyloctyl)-2-[(1R, 3S)-3-Hydroxycyclohexyl]-Phenol;
or some trade or other names; Cannabicyclohexanol; CP447, 497 C8 Homologue; or (6)
fentanyl analogues such as furanyl fentanyl, acetyl fentanyl, and 4 NAPP (desoropionyl
fentanyl); or (7) a material, compound, mixture or preparation in any form that contains
the component Salvinorin A, or as a concentrated extract of the chemical Salvinorin
A; or (8) any analogue of a synthetic cannabinoid, synthetic phenethylamine or cannabimimetic
agent meaning a substance that has a chemical structure that is substantially similar
to the chemical structure of a substance defined by part 9 of title 10 of the New
York codes, rules and regulations as of the date of the violation, or as included
in schedule I of the federal drug enforcement administration schedules of controlled
substances, as listed in section 1308.11 of title 21 of the code of federal regulations,
or successor regulation, as of the date of the violation, or any cannabimimetic agent,
as defined in section 812 of title 21 of the United States code, as of the date of
the violation and has a stimulant, depressant, or hallucinogenic effect on the central
nervous system that is substantially similar to or greater than the stimulant depressant
or hallucinogenic effect on the central nervous system of such a substance defined
by part 9 of title 10 of the New York codes, rules and regulations as of the date
of the violation, or as included in schedule I of the federal drug enforcement administration
schedules of controlled substances, as listed in section 1308.11 of title 21 of the
code of federal regulations, or successor regulation, as of the date of the violation,
or any cannabimimetic agent, as defined in section 812 of title 21 of the United States
code, as of the date of the violation; or (9) any other non-prescription substance
or compound developed prior to or subsequent to the adoption of this section which
has a chemical structure and/or pharmacological effect substantially similar to, or
which otherwise mimics the active ingredient of marijuana, cocaine, heroin or any
other controlled substance.
